Roche Transfection Research Award 2007

Win a trip to the 2007 ASCB Meeting in Washington, D.C.

(PresseBox) ( Mannheim, )
For over a decade, FuGENE® Transfection Reagents have been associated with leading research labs the world over, making an impact and leaving a permanent mark within the industry. Their innovative advanced technology has led to the successful transfection of more than 800 different cell types. FuGENE® Transfection Reagents have been referenced in over 10,000 publications covering a broad spectrum of different applications.

Roche Applied Science now offers researchers working with FuGENE the opportunity to be selected for this year’s Transfection Research Award, which is to be presented at the ASCB annual meeting in Washington D.C. Participants are required to submit a short application article on the use of FuGENE® 6/HD Transfection Reagent online at www.roche-applied-science.com/... .
Deadline is October 12, 2007.

The three best submitted scientific articles, chosen by an RAS scientific committee, will be invited to present their data at the ASCB 47th annual meeting in December of this year. RAS will cover the cost of airfares, accommodation, and full meeting registration for all winners.

An additional 20 prizes of the hardcover copy of “Untamed”, a compilation of Steve Bloom’s spectacular wildlife photographs, are also to be awarded to the runners up.
The publisher indicated in each case is solely responsible for the press releases above, the event or job offer displayed, and the image and sound material used (see company info when clicking on image/message title or company info right column). As a rule, the publisher is also the author of the press releases and the attached image, sound and information material.
The use of information published here for personal information and editorial processing is generally free of charge. Please clarify any copyright issues with the stated publisher before further use. In the event of publication, please send a specimen copy to service@pressebox.de.